Animal research deserves defending

22 October 2009

In the wake of actions such as animal rights activists setting fire to the holiday home of Swiss drug major Novartis' chief executive Daniel Vasella's holiday home in Austria, and previously desecrating the graves of relatives, stealing the remains of his mother (The Pharma Letter August 11), Faculty of 1000 Biology members have throw their support behind a call to educate the public about animal research.

In a recent commentary, 'We must face the threats,' in the Journal of Neuroscience, researchers Dario Ringach and David Jentsch spoke out against animal rights extremism. They urged the scientific community to stand together and fight misconceptions about experiments using animals. That their plea has been heard is clear from the unanimously positive response it received on the Faculty of 1000 Biology web site.

Faculty of 1000 Biology is an on-line service where leading researchers from around the world review papers in their field that catch their eye. Faculty members choose the articles they highlight and rarely has a paper received as much attention and praise as this piece on animal rights extremism. Within a week it became the most highly-rated paper of the past few years.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight